This presentation focuses on the challenges and opportunities in India’s healthcare system highlighted by the COVID-19 pandemic. It emphasizes the need for an overhaul in both the strategy and infrastructure of healthcare, including expanding and integrating primary, secondary, and tertiary care while leveraging India’s pharmaceutical strengths.